Dr. Pentel was informative and professional and gave me some skin care suggestions. I could tell right off the bat that she was being honest with her suggestions and knew just what I needed.
Since 1984, BTX has been used to treat the symptoms of thousands of people with SD and its efficacy and safety have been documented in numerous medical publications. Furthermore, the American Academy of Otolaryngology & Head and Neck Surgery has documented the use of BTX for SD in a policy statement. Its use by physicians to treat SD is considered off-label” by the FDA. However many other medicines are used successfully off-label for a number of conditions and this designation does not limit a physician’s use of a medicine.
BOTOX Cosmetic is a high performing wrinkle reducer to eliminate lines and facial wrinkles with visible results. The American Society for Aesthetic Plastic Surgery ranked BOTOX Cosmetic as the most popular physician-administered aesthetic procedure in the United States for the fourth year in a row (surgical and non-surgical combined). The treatments help revitalize your appearance and take away that older, tired look.
Tiny quantities of the toxin are injected directly into the affected muscles. It takes three to five small injections between the eyebrows to treat the frown line. The injection is almost painless. The treated muscles weaken over the following week or so. Most people do not notice anything. They simply become aware that they are no longer able to contract the frown muscles. They can still lift their eyebrows normally and blink without problems.
BTX-A is now a common treatment for muscles affected by the upper motor neuron syndrome (UMNS), such as cerebral palsy , for muscles with an impaired ability to effectively lengthen Muscles affected by UMNS frequently are limited by weakness , loss of reciprocal inhibition , decreased movement control and hypertonicity (including spasticity ). In January 2014, Botulinum toxin was approved by UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of ankle disability due to lower limb spasticity associated with stroke in adults. 45 Joint motion may be restricted by severe muscle imbalance related to the syndrome, when some muscles are markedly hypertonic, and lack effective active lengthening. Injecting an overactive muscle to decrease its level of contraction can allow improved reciprocal motion, so improved ability to move and exercise.
In a longitudinal follow-up of 89 patients treated with review for dystonia ( cervical dystonia , blepharospasm and oromandibular dystonia), prolonged and sustained therapeutic benefits with repeat injections were seen over time 42 The mean duration of follow-up was 18.5 years and a total of 4133 visits were recorded. Approximately 10% of the visits noted side effects for cervical dystonia, 9.5% for blepharospasm and 7% with oromandibular dystonia. Tolerable adverse effects were reported in 19% of patients. These data, which arise from the longest follow-up and largest series of dystonia treated with botulinum toxin, confirm the long-term efficacy and safety of botulinum toxin.